CD274 and cervical cancer: Therapeutic interventions, such as immune checkpoint blockade targeting molecules like PD-1/PD-L1 and CTLA-4, aim to overcome this challenge; they are not specific for HPV antigens, and if successful, they can be efficient in the majority of cervical cancer cases, regardless of the associated HPV type (9).